Fig. 2: The expression of ZNF652 was correlated with clinical outcomes of LC patients. | Cell Death & Disease

Fig. 2: The expression of ZNF652 was correlated with clinical outcomes of LC patients.

From: ZNF652 exerts a tumor suppressor role in lung cancer by transcriptionally downregulating cyclin D3

Fig. 2

A OS analysis for LC patients with high or low levels of ZNF652 using the HPA dataset database. B Kaplan–Meier survival analysis of OS for LC patients with high or low levels of ZNF652 expression. C GSCA analysis of ZNF652 expression level and trend in different stages in LUAD and LUSC. D Expression level of ZNF652 in different stages in the GEO database (GSE11969).

Back to article page